A. Sherk

发表

A negative coregulator for the human ER.

D. McDonnell, J. Norris, D. Fan, 2002, Molecular endocrinology.

Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators.

B. Wittmann, D. McDonnell, Bryan M. Wittmann, 2007, Cancer research.

1α,25-Dihydroxyvitamin D3 (calcitriol) and its analogue, 19-nor-1α,25(OH)2D2, potentiate the effects of ionising radiation on human prostate cancer cells

S. Cramer, C. Koumenis, G. Schwartz, 2003, British Journal of Cancer.

Molecular Pharmacology of Estrogen and Progesterone Receptors

D. McDonnell, A. Sherk, 2007 .

Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands.

T. Willson, X. Deng, E. Anderson, 2009, Chemistry & biology.

Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic.

N. Laping, D. Kazmin, S. Thompson, 2008, Cancer research.

ELF3 is a repressor of androgen receptor action in prostate cancer cells

Jeff S. Jasper, V. Giguère, J. Jasper, 2014, Oncogene.

Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro.

Qianben Wang, D. McDonnell, D. Frigo, 2009, Molecular endocrinology.

in Vitro Increased CXCR4-Dependent Migration of Prostate Cancer Cells Induction of Krüppel-Like Factor 5 Expression by Androgens Results in

Qianben Wang, D. McDonnell, D. Frigo, 2009 .